• 2007 March 01

Company Description

3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.

3-V Biosciences is a privately held biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases. 3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield & Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in Zürich, Switzerland in close proximity to the companyâ€s founders at the ETH (Swiss Federal Institute of Technology) and the University of Zürich. Host pathway screening began in November 2007 and continues today.

  • Manufacturer:

    Science and Engineering
  • Formed:

    July 1, 2007
  • Founders:

    Lucas Pelkmans
  • Company Website:

  • Company E-mail:

  • Company Address:

    1050 Hamilton Court
    Menlo Park, CA
    United States
  • CEO:

    • Lucas Pelkmans